GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - NEJM
How durable is gene therapy for haemophilia B? - Nature
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada - Yahoo Finance
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen - Frontiers
Building safeguards for gene therapy in haemophilia - The Lancet
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - Business Wire
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
Exploring gene editing as a potential therapeutic strategy for hemophilia - Frontiers
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
AAV Gene Therapy in Severe Hemophilia B - NEJM
Pfizer receives EC approval for Hympavzi to treat haemophilia - Yahoo
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
Comparing Real-World Outcomes of Prophylaxis with Extended Half-life Factor IX (rIX-FP vs. rFIXFc and N9-GP) for Haemophilia B: An Analysis of Medical Chart Data from Germany - springermedicine.com
Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight - Barchart
Netherlands Temporarily Includes Hympavzi in Basic Package for Hemophilia A & B - NAVLIN DAILY
First-in-human trial of hemophilia B treatment BE-101 starts dosing - Hemophilia News Today
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients - PMLiVE
Eloctate, Alprolix control bleeds in hemophilia patients’ major surgeries - Hemophilia News Today
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - NEJM
First German haemophilia B patient receives gene therapy HEMGENIX - PharmaTimes
Routine dental work safe in hemophilia patients with clotting factor boost - Hemophilia News Today
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - NEJM
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - Yahoo Finance
Hull teenager first to be treated with new haemophilia drug - BBC
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - NEJM
Extended hemophilia half-life products aid care, but raise costs - Hemophilia News Today
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - AJMC
Haemophilia A vs B: Which is more severe? Here’s what sets them apart - TheHealthSite
The National “New Methods” Decision Forum in Norway recommends CSL’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B without a history of Factor IX inhibitors - Mynewsdesk
Canadian first: One-time gene therapy given to London, Ont., hemophilia B patient - CTV News
CSL’s haemophilia therapy shows durable five-year benefits in landmark trial results - BiotechDispatch
FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use - Pharmacy Times
Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors - GOV.UK
First Patient in Germany Treated With Hemgenix for Hemophilia B - NAVLIN DAILY
Spotlight on the ISTH Hemophilia Treatment Guidelines and Alternate Recommendations - Hematology Advisor
First gene therapy to treat haemophilia B - European Medicines Agency (EMA)
Pfizer reports positive results from Phase III BASIS trial for haemophilia - Clinical Trials Arena
Haemophilia gene therapy patients thriving over a decade after treatment - UCL | University College London
How pioneering gene therapy changed the life of the first man in Wales to receive it - Nation.Cymru
One dose of gene therapy gives years of relief from blood disorder - Nature
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
Switching to Extended Half-Life Therapies Improves Hemophilia Care, but Raises Short-Term Costs - Managed Healthcare Executive
Pfizer says patient dies after receiving hemophilia drug in trial - ETPharma.com
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
Non-replacement therapy for people with haemophilia B: another step towards health equity - The Lancet
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - NEJM
Transformational therapy cures haemophilia B - BBC
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - NEJM
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system - Nature
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice - Nature
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors - NEJM
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Medicine
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Hemophilia B Gene Therapy Produces Durable Response for 90% of Participants - AJMC
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond - The Lancet
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - NEJM
Researchers welcome $3.5-million haemophilia gene therapy — but questions remain - Nature
CSL doses first patient with haemophilia B gene therapy Hemgenix - Pharmaceutical Technology
Novo Nordisk’s Alhemo Recommended for Expanded Use in Europe for Haemophilia A and B - Insider Monkey
Gene Therapy for Hemophilia B Could Lower Health Plans’ Budget Over Time - AJMC
Freeline Therapeutics doses first subject in haemophilia B therapy trial - Clinical Trials Arena
Haemophilia - The Lancet
FDA Approves One-Time Gene Therapy Fidanacogene Elaparvovec for Hemophilia B - AJMC
CRISPR/Cas9 for hemophilia - Hemophilia News Today
Pfizer’s hemophilia B gene therapy inches closer to regulatory approval - BioPharma Dive
Etranacogene Dezaparvovec Gene Therapy Outperforms FIX Products in Hemophilia B - AJMC
Gene therapy BBM-H901 approved for hemophilia B in China - Hemophilia News Today
Hemophilia B Market Size to Reach USD 24.7 Billion by 2035, Impelled by Advancements in Gene Therapy - BioSpace
FDA approves first gene therapy for hemophilia B - BioPharma Dive
Phase 1/2 clinical trial of BE-101 now enrolling hemophilia B patients - Hemophilia News Today
uniQure announces FDA approval of first gene therapy for adults with hemophilia B - uniqure.gcs-web.com
Characteristics of FXa-storing platelets in hemophilia B mice and the influence of alcohol on the platelets - Nature
Intellia ending work with Regeneron on gene therapy for hemophilia B - Hemophilia News Today
In about-face, hemophilia B therapy Hemgenix to be covered by NHS - Hemophilia News Today
After 4 years, hemophilia B bleeding rates remain low with Hemgenix - Hemophilia News Today
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemmophilia b,   haemoohilia b,   gaemophilia b,   haemophili b,   haemophilis b,   hemophilia b,   haemohilia b,   haemopihlia b,   heamophilia b,   haemophiila b,   haemophilia n,   haempphilia b,   haemophilia v,   haemophiia b,   haemophhilia b,   haemophi;ia b,   haemophilia ,   haemophiliab,   haempohilia b,   haenophilia b,   haaemophilia b,   haemohpilia b,   haemopilia b,   haemophiloa b,   haemophili ab,   haemo[hilia b,   ahemophilia b,   haemophilia bb,   hsemophilia b,   jaemophilia b,   haemophikia b,   haemophiilia b,   haemophilua b,   harmophilia b,   aemophilia b,   hhaemophilia b,   haeophilia b,   haemophilia b,   haemophilai b,   haeemophilia b,   haemopphilia b,   hae,ophilia b,   haemophliia b,   haemopholia b,   haemiphilia b,   haemopjilia b,   haemoophilia b,   hawmophilia b,   haemophlia b,   haemophila b,   haemophillia b,   haeomphilia b,   haemophulia b,   haemophiliia b,   haemophiliaa b,   hameophilia b,   hamophilia b,   haemphilia b,   haemophiliab ,   haemopgilia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z